U.S. Markets open in 16 mins.

Tanaka Growth (TGFRX)


Nasdaq - Nasdaq Delayed Price. Currency in USD
Add to watchlist
21.83+0.21 (+0.97%)
At close: 8:01PM EDT
People also watch
TOPPXBMGAXTFFYXLGOAXETGLX
Full screen
Previous Close21.62
YTD Return3.80%
Expense Ratio (net)2.31%
CategoryN/A
Morningstar Rating
Morningstar Risk Rating★★★★★
Last Cap GainN/A
Net Assets14.69M
Beta (3y)1.43
Yield0.00%
Holdings Turnover76.98%
Last DividendN/A
Inception DateDec 30, 1998
Average for CategoryN/A
  • Reuterslast year

    Growth funds dumping Apple stock as iPhone sales seen sagging; value-managers moving in

    Major U.S. growth mutual funds have been among the largest sellers of Apple Inc shares over the past six months, fueling speculation that the company's days of supercharged growth have come to an end. Amid concerns that iPhone sales may be set to drop, the $77.3 billion American Funds Capital World Growth & Income Fund has sold all of its 1.7 million Apple shares since the end of June, according to Lipper data. The $9.3 billion Hartford Capital Appreciation Fund sold 1.4 million shares over the same period, reducing its position by 91 percent.

  • Reuters2 years ago

    Fund managers boost bets on health care even amid high prices

    Last July, when Federal Reserve Chair Janet Yellen spurred a sell-off in healthcare stocks by saying that valuations in shares of biotech companies looked "stretched," portfolio manager Graham Tanaka saw an opportunity. After a year-long buying spree, he now has more than a quarter of his $17 million Tanaka Growth fund portfolio in healthcare companies such as Gilead Sciences Inc, up from just 5 percent at the start of last year. In the eleven months since Yellen's warning, other fund managers have benefitted by shaking off concerns about high valuations and increasing their holdings of healthcare companies.

  • We're sorry this is all we were able to find about this topic.